Merck & Company, Inc. (MRK)

91.89 0.23%
Jun 29 close; Powered by IEX
Pros
Revenue growth higher than the industry and sector averages
Forward dividend yield higher than the industry and sector averages
Forward PEG ratio low relative to industry peers
Buy analyst rating
Cons
Company’s profitability is declining

Pros

  1. MRK quarterly revenue growth was 49.60%, higher than the industry and sector average revenue growth (11.10% and 7.51%, respectively). See MRK revenue growth chart.
  2. MRK forward dividend yield is 3.05%, higher than the industry (2.43%) and sector (0.20%) forward dividend yields. See MRK forward dividend chart.
  3. MRK PEG ratio (P/E adjusted for growth) is 1.02, which is low compared to its industry peers’ PEG ratios. See MRK PEG chart.
  4. MRK average analyst rating is Buy. See MRK analyst rating chart.

Cons

  1. MRK profitability is declining. The YoY profit margin change was -3.88 percentage points. See MRK profitability chart.